Drug intelligence / Profile preview

lemon balm dry extract

Development stage
Unknown
Lead developer
Galen-N
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Lemon balm dry extract is a botanical extract derived from the leaves of *Melissa officinalis* (lemon balm), a perennial herb in the mint family. It is widely used as a dietary supplement and traditional herbal medicine for its calming, anxiolytic, and spasmolytic properties. The extract is typically standardized to its primary active constituent, rosmarinic acid (often 5% to 12% by HPLC), which is responsible for much of its therapeutic activity. Mechanistically, lemon balm dry extract acts primarily by inhibiting 4-aminobutyrate aminotransferase (ABAT, or GABA transaminase), the enzyme responsible for degrading the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), thereby increasing GABA levels in the brain. It also modulates GABA-A receptors, inhibits acetylcholinesterase (AChE) and monoamine oxidase (MAO), and interacts with cholinergic (muscarinic and nicotinic) receptors. These combined actions contribute to its clinical use in relieving mild symptoms of mental stress, anxiety, and insomnia, as well as alleviating gastrointestinal discomfort.

Other names
Melissa dry extractMelissa officinalis dry extractMelissa officinalis extractlemon balm extract
02

Targets

ABAT (4-aminobutyrate aminotransferase)AcetylcholinesteraseGABRR (GABA-A receptor subunit rho)MAOA (Monoamine oxidase A)mAChR (Muscarinic acetylcholine receptors)Nicotinic Acetylcholine ReceptorGABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on lemon balm dry extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lemon balm dry extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call